These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


548 related items for PubMed ID: 18669460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment choice and quality of care for men with localized prostate cancer.
    Miller DC, Spencer BA, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT, Litwin MS.
    Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
    [Abstract] [Full Text] [Related]

  • 3. The quality of surgical pathology care for men undergoing radical prostatectomy in the U.S.
    Miller DC, Spencer BA, Shah RB, Ritchey J, Stewart AK, Gay EG, Dunn RL, Wei JT, Litwin MS.
    Cancer; 2007 Jun 15; 109(12):2445-53. PubMed ID: 17492683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quality-of-care indicators for early-stage prostate cancer.
    Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS.
    J Clin Oncol; 2003 May 15; 21(10):1928-36. PubMed ID: 12743145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J, Pashos CL, Henning JM, Litwin MS.
    Cancer; 2000 Oct 15; 89(8):1792-9. PubMed ID: 11042575
    [Abstract] [Full Text] [Related]

  • 8. Assessing the quality of prostate cancer care.
    Penson DF.
    Curr Opin Urol; 2008 May 15; 18(3):297-302. PubMed ID: 18382239
    [Abstract] [Full Text] [Related]

  • 9. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.
    Miller DC, Litwin MS, Sanda MG, Montie JE, Dunn RL, Resh J, Sandler H, Wei JT.
    Cancer; 2003 Mar 15; 97(6):1428-35. PubMed ID: 12627506
    [Abstract] [Full Text] [Related]

  • 10. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM, Porter MP, Soloway MS.
    J Urol; 2008 Nov 15; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quality of care indicators for prostate cancer: progress toward consensus.
    Miller DC, Saigal CS.
    Urol Oncol; 2009 Nov 15; 27(4):427-34. PubMed ID: 19573774
    [Abstract] [Full Text] [Related]

  • 13. Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.
    Owen JB, White JR, Zelefsky MJ, Wilson JF.
    J Am Coll Radiol; 2009 Jun 15; 6(6):442-7. PubMed ID: 19467491
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Geographic and socioeconomic variation in the treatment of prostate cancer.
    Krupski TL, Kwan L, Afifi AA, Litwin MS.
    J Clin Oncol; 2005 Nov 01; 23(31):7881-8. PubMed ID: 16204005
    [Abstract] [Full Text] [Related]

  • 20. [Curative treatment of prostatic cancer in Norway in 1998 and 2001].
    Kvåle R, Skarre E, Tønne A, Kyrdalen AE, Norstein J, Angelsen A, Wahlqvist R, Fosså SD.
    Tidsskr Nor Laegeforen; 2006 Mar 23; 126(7):912-6. PubMed ID: 16554883
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.